Chiba, Japan

Ryoichi Yoshimura

This inventor holds 1 USPTO granted patent. Top assignee: National Institute of Radiological Sciences. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryoichi Yoshimura. Retrieved from https://idiyas.com/inventor/ryoichi-yoshimura-8wa2fc0r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ryoichi Yoshimura: Innovator in Cancer Prediction Technologies

Introduction

Ryoichi Yoshimura is a prominent inventor based in Chiba, Japan, known for his contributions to the field of cancer diagnostics. With a focus on the early detection of metastasis in oral cavity cancer, his innovative work aims to improve patient outcomes through scientific advancements.

Latest Patents

Yoshimura holds a patent for a groundbreaking method entitled "Method of predicting metastasis of oral cavity cancer into cervical lymph node and diagnosis kit to be used in the prediction." This method provides a way to objectively predict the likelihood of metastasis at an early stage for individuals diagnosed with oral cavity cancer. The process includes assaying the expression amounts of specific metastasis prediction genes, where the gene expressions differ between patients with and without metastasis. Notably, the method focuses on the genes MSR1 and RET, crucial for determining the metastasis risk.

Career Highlights

Ryoichi Yoshimura is affiliated with the National Institute of Radiological Sciences, a reputable research institution dedicated to advancing knowledge in radiological technologies and applications. His work at this institution reflects a commitment to uncovering new avenues in cancer diagnostics, thereby enhancing the precision of medical predictions.

Collaborations

In his research endeavors, Yoshimura collaborates closely with esteemed colleagues such as Takashi Imai and Mayumi Iwakawa. Together, they contribute to the advancement of cancer research and diagnostics, pooling their expertise to foster innovative solutions that can be translated into clinical practice.

Conclusion

Ryoichi Yoshimura stands out as an innovator whose patent reflects a significant advancement in the early prediction of oral cavity cancer metastasis. Through his work at the National Institute of Radiological Sciences and collaboration with talented coworkers, he continues to push the boundaries of medical science, ensuring a brighter future for cancer patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…